Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 5 Pain 2 Chronic Pain 2 Breast Neoplasms 2 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neuralgia 1 Neoplasms 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Cancer Patient 1 Brain Neoplasms 1 Astrocytoma 1 Acute Pain 1

Interventions

Sorafenib 42 Bevacizumab 16 Oxaliplatin 13 Radiosurgery 10 Gemcitabine 10 Doxorubicin 10 Capecitabine 10 Leucovorin 9 Hepatectomy 9 Fluorouracil 9 Cisplatin 9 Radiofrequency Ablation 8 Nivolumab 8 pembrolizumab 7 Drug Therapy 7 Carboplatin 7 Irinotecan 6 Cryosurgery 6 Talaporfin 5 Mitomycin 5 Everolimus 5 Erlotinib Hydrochloride 5 Electroporation 5 spartalizumab 4 Sunitinib 4 Melphalan 4 Ipilimumab 4 Epirubicin 4 Embolization, Therapeutic 4 regorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Neoplasms × Pregabalin × Clear all

NCT03151213 2026-03-13

pregabalin

Tanta University

Phase 4 Completed

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡